Cantor Fitzgerald Analyst Ratings & Stock Recommendations

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Cantor Fitzgerald. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Cantor Fitzgerald.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
11/13/2018Cantor FitzgeraldSet Price TargetAMAG Pharmaceuticals (AMAG)Hold $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetKalvista Pharmaceuticals (KALV)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetAimmune Therapeutics (AIMT)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldLowers TargetPTC Therapeutics (PTCT)Overweight -> Overweight$66.00 -> $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018Cantor FitzgeraldSet Price TargetMesoblast (MESO)Buy $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018Cantor FitzgeraldDowngradesPacific Biosciences of California (PACB)Overweight -> Neutral $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesTheravance Biopharma (TBPH)Buy $55.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldSet Price TargetAnaptysBio (ANAB)Buy $140.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesTESARO (TSRO)Buy $68.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesNeos Therapeutics (NEOS)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldSet Price TargetSeres Therapeutics (MCRB)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018Cantor FitzgeraldReiteratesHTG Molecular Diagnostics (HTGM)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesNational Health Investors (NHI)Hold $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesAlnylam Pharmaceuticals (ALNY)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018Cantor FitzgeraldReiteratesSquare (SQ)Overweight$76.00 -> $91.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $27.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesArena Pharmaceuticals (ARNA)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesDermira (DERM)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesGenesis Healthcare (GEN)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesMenlo Therapeutics (MNLO)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetEvofem Biosciences (EVFM)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesIntra-Cellular Therapies (ITCI)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetReata Pharmaceuticals (RETA)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetMomenta Pharmaceuticals (MNTA)Hold $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldDowngradesAAC (AAC)Overweight -> Neutral $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetACADIA Pharmaceuticals (ACAD)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetCymaBay Therapeutics (CBAY)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetCara Therapeutics (CARA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesGenpact (G)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018Cantor FitzgeraldReiteratesDXC Technology (DXC)Hold $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesAclaris Therapeutics (ACRS)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesJazz Pharmaceuticals (JAZZ)Buy $201.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldInitiatesProteostasis Therapeutics (PTI)Buy $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesValeant Pharmaceuticals (VRX)BuyN/AView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetANI Pharmaceuticals (ANIP)Buy $74.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesTabula Rasa HealthCare (TRHC)Buy $99.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldReiteratesXencor (XNCR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldSet Price TargetNeurocrine Biosciences (NBIX)Buy $150.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018Cantor FitzgeraldSet Price TargetAlder Biopharmaceuticals (ALDR)Hold $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesTivity Health (TVTY)Buy $49.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesMylan (MYL)Hold $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesAlkermes (ALKS)Neutral -> Neutral$46.00 -> $41.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesCaretrust REIT (CTRE)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldRaises TargetAcelRx Pharmaceuticals (ACRX)Overweight$8.00 -> $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldRaises TargetHMS (HMSY)Neutral $31.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldSet Price TargetGalmed Pharmaceuticals (GLMD)Buy $59.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018Cantor FitzgeraldReiteratesAbeona Therapeutics (ABEO)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018Cantor FitzgeraldReiteratesBioMarin Pharmaceutical (BMRN)Buy $126.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018Cantor FitzgeraldDowngradesAdverum Biotechnologies (ADVM)Overweight -> Hold$12.00 -> $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldRaises TargetU.S. Physical Therapy (USPH)Neutral -> Neutral$103.00 -> $107.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldRaises TargetThe Ensign Group (ENSG)Overweight -> Overweight$42.00 -> $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldRaises TargetEmergent Biosolutions (EBS)Overweight -> Overweight$68.00 -> $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldRaises TargetEPAM Systems (EPAM)Overweight -> Overweight$139.00 -> $146.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldSet Price TargetAcelRx Pharmaceuticals (ACRX)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldReiteratesCorcept Therapeutics (CORT)Hold -> Hold $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldSet Price TargetAMAG Pharmaceuticals (AMAG)Hold $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldUpgradesbluebird bio (BLUE)Underweight -> Neutral$122.00 -> $134.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldSet Price TargetT2 Biosystems (TTOO)Buy $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldSet Price TargetCytokinetics (CYTK)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018Cantor FitzgeraldReiteratesPuma Biotechnology (PBYI)Overweight -> Buy$75.00 -> $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldReiteratesComputer Programs & Systems (CPSI)Hold $28.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldDowngradesAllscripts Healthcare Solutions (MDRX)Overweight -> Neutral $12.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldReiteratesRevance Therapeutics (RVNC)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldDowngradesEagle Pharmaceuticals (EGRX)Overweight -> NeutralHighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldSet Price TargetPacific Biosciences of California (PACB)Buy $8.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldRaises TargetHCP (HCP)Overweight -> Overweight$29.00 -> $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldRaises TargetACADIA Pharmaceuticals (ACAD)Overweight -> Overweight$27.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldReiteratesAmarin (AMRN)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/1/2018Cantor FitzgeraldLowers TargetIntegra Lifesciences (IART)Neutral -> Neutral$59.00 -> $54.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldSet Price TargetAcorda Therapeutics (ACOR)Hold $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldSet Price TargetACADIA Pharmaceuticals (ACAD)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $19.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Buy $17.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldLowers TargetCommunity Health Systems (CYH)Neutral -> Neutral$6.00 -> $4.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldRaises TargetGlobal Payments (GPN)Overweight -> Overweight$136.00 -> $143.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldRaises TargetFidelity National Information Servcs (FIS)Overweight -> Overweight$117.00 -> $122.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldLowers TargetNextgen Healthcare (NXGN)Overweight -> Overweight$26.00 -> $23.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldReiteratesAmgen (AMGN)Hold $223.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldReiteratesKindred Biosciences (KIN)Overweight -> Buy$20.00 -> $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/31/2018Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018Cantor FitzgeraldReiteratesWellCare Health Plans (WCG)Buy $330.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018Cantor FitzgeraldReiteratesAetna (AET)Hold $204.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018Cantor FitzgeraldSet Price TargetEvofem Biosciences (EVFM)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $50.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018Cantor FitzgeraldLowers TargetAxoGen (AXGN)Overweight -> Overweight$45.00 -> $43.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/30/2018Cantor FitzgeraldSet Price TargetEagle Pharmaceuticals (EGRX)Buy $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018Cantor FitzgeraldReiteratesFirst Data (FDC)Neutral -> Hold$23.00 -> $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018Cantor FitzgeraldLowers TargetMoody's (MCO)Neutral $145.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018Cantor FitzgeraldSet Price TargetRigel Pharmaceuticals (RIGL)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/29/2018Cantor FitzgeraldReiteratesCaretrust REIT (CTRE)Buy $20.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018Cantor FitzgeraldLowers TargetCerner (CERN)Overweight -> Overweight$80.00 -> $75.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018Cantor FitzgeraldRaises TargetOmnicell (OMCL)Overweight -> Overweight$63.00 -> $70.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018Cantor FitzgeraldSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $8.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018Cantor FitzgeraldSet Price TargetBioMarin Pharmaceutical (BMRN)Buy $126.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/26/2018Cantor FitzgeraldRaises TargetGilead Sciences (GILD)Overweight -> Overweight$87.00 -> $88.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018Cantor FitzgeraldReiterateseHealth (EHTH)Buy $39.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018Cantor FitzgeraldReiteratesAnthem (ANTM)Buy $275.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018Cantor FitzgeraldReiteratesWNS (WNS)Buy $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/25/2018Cantor FitzgeraldSet Price TargetAcelRx Pharmaceuticals (ACRX)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/24/2018Cantor FitzgeraldSet Price TargetCollegium Pharmaceutical (COLL)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018Cantor FitzgeraldReiteratesAlkermes (ALKS)Hold $46.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018Cantor FitzgeraldSet Price TargetIntra-Cellular Therapies (ITCI)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018Cantor FitzgeraldReiteratesAlder Biopharmaceuticals (ALDR)Hold $21.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/23/2018Cantor FitzgeraldSet Price TargetGlobal Blood Therapeutics (GBT)Buy $96.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $56.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldRaises TargetDynavax Technologies (DVAX)Overweight $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldRaises TargetRegeneron Pharmaceuticals (REGN)Neutral $441.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldInitiatesRA Medical Systems (RMED)Overweight $21.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldReiteratesTheravance Biopharma (TBPH)Buy $55.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldReiteratesCorbus Pharmaceuticals (CRBP)Buy $36.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/22/2018Cantor FitzgeraldRaises TargetTESARO (TSRO)Overweight -> Positive$57.00 -> $68.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/21/2018Cantor FitzgeraldReiteratesIncyte (INCY)Neutral -> Hold$73.00 -> $74.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/21/2018Cantor FitzgeraldReiteratesPacific Biosciences of California (PACB)Buy $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018Cantor FitzgeraldReiteratesNuVasive (NUVA)Hold $58.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018Cantor FitzgeraldSet Price TargetDynavax Technologies (DVAX)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018Cantor FitzgeraldRaises TargetEndo International (ENDP)Neutral -> Neutral$12.00 -> $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/19/2018Cantor FitzgeraldReiteratesIntuitive Surgical (ISRG)Buy $620.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018Cantor FitzgeraldReiteratesAcadia Healthcare (ACHC)Hold $39.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018Cantor FitzgeraldReiteratesHorizon Pharma (HZNP)Buy $21.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/18/2018Cantor FitzgeraldSet Price TargetBiohaven Pharmaceutical (BHVN)Buy $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Cantor FitzgeraldReiteratesGlobal Blood Therapeutics (GBT)Buy $96.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Cantor FitzgeraldReiteratesZoetis (ZTS)Overweight$98.00 -> $105.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Cantor FitzgeraldReiteratesEli Lilly And Co (LLY)Buy $128.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Cantor FitzgeraldReiteratesPfizer (PFE)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Cantor FitzgeraldSet Price TargetCytokinetics (CYTK)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/17/2018Cantor FitzgeraldLowers TargetIBM (IBM)Neutral -> Neutral$152.00 -> $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/16/2018Cantor FitzgeraldReiteratesAnaptysBio (ANAB)Buy $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Cantor FitzgeraldSet Price TargetBioMarin Pharmaceutical (BMRN)Buy $126.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Cantor FitzgeraldRaises TargetACADIA Pharmaceuticals (ACAD)Overweight -> Overweight$25.00 -> $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Cantor FitzgeraldSet Price TargetAimmune Therapeutics (AIMT)Buy $62.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Cantor FitzgeraldReiteratesKrystal Biotech (KRYS)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/14/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Cantor FitzgeraldSet Price TargetAcelRx Pharmaceuticals (ACRX)Buy $8.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/15/2018Cantor FitzgeraldReiteratesInvesco DWA Utilities Momentum ETF (PTE)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/12/2018Cantor FitzgeraldReiteratesBiohaven Pharmaceutical (BHVN)Buy $57.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldReiteratesCommunity Health Systems (CYH)Hold $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldInitiatesInternational Money Express (IMXI)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldInitiatesFoamix Pharmaceuticals (FOMX)OverweightLowView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldSet Price TargetPacific Biosciences of California (PACB)Buy $8.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldReiteratesArrowhead Pharmaceuticals (ARWR)Buy $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldRaises TargetAmedisys (AMED)Neutral$117.00 -> $125.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/11/2018Cantor FitzgeraldInitiatesNightstar Therapeutics (NITE)Overweight $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/10/2018Cantor FitzgeraldSet Price TargetMomenta Pharmaceuticals (MNTA)Hold $24.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Cantor FitzgeraldReiteratesPerrigo (PRGO)Buy $107.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Cantor FitzgeraldRaises TargeteHealth (EHTH)Overweight $39.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Cantor FitzgeraldReiteratesMenlo Therapeutics (MNLO)Buy $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/7/2018Cantor FitzgeraldSet Price TargetBioDelivery Sciences International (BDSI)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/7/2018Cantor FitzgeraldSet Price TargetBioMarin Pharmaceutical (BMRN)Buy $126.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Cantor FitzgeraldSet Price TargetAcelRx Pharmaceuticals (ACRX)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/8/2018Cantor FitzgeraldSet Price TargetAmgen (AMGN)Neutral $223.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/5/2018Cantor FitzgeraldRaises TargetAmarin (AMRN)$15.00 -> $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldSet Price TargetSupernus Pharmaceuticals (SUPN)Buy $56.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldSet Price TargetEvofem Biosciences (EVFM)Buy $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldRaises TargetArrowhead Pharmaceuticals (ARWR)Overweight$18.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldReiteratesSeaSpine (SPNE)Overweight $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetANI Pharmaceuticals (ANIP)Buy $74.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesInvesco DWA Utilities Momentum ETF (PTE)OverweightHighView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldReiteratesIntra-Cellular Therapies (ITCI)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldReiteratesCara Therapeutics (CARA)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/4/2018Cantor FitzgeraldSet Price TargetOpiant Pharmaceuticals (OPNT)Buy $42.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetSpring Bank Pharmaceuticals (SBPH)Buy $35.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $8.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesRigel Pharmaceuticals (RIGL)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetOcular Therapeutix (OCUL)Buy $22.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetUniqure (QURE)Buy $58.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetEagle Pharmaceuticals (EGRX)Buy $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesGenesis Healthcare (GEN)Buy $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesDeciphera Pharmaceuticals (DCPH)Buy $53.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetAdverum Biotechnologies (ADVM)Buy $12.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldSet Price TargetKalvista Pharmaceuticals (KALV)Buy $32.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesVanda Pharmaceuticals (VNDA)Hold $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesCytokinetics (CYTK)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesCerus (CERS)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/3/2018Cantor FitzgeraldReiteratesViewray (VRAY)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldReiteratesAerie Pharmaceuticals (AERI)Buy $86.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldSet Price TargetGlobal Blood Therapeutics (GBT)Buy $96.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldSet Price TargetStrongbridge Biopharma (SBBP)Buy $17.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldSet Price TargetArrowhead Pharmaceuticals (ARWR)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldSet Price TargetGalmed Pharmaceuticals (GLMD)Buy $59.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetCorcept Therapeutics (CORT)Hold $17.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldSet Price TargetHalozyme Therapeutics (HALO)Buy $27.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldSet Price TargetACADIA Pharmaceuticals (ACAD)Buy $25.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/2/2018Cantor FitzgeraldReiteratesZynerba Pharmaceuticals (ZYNE)Buy $21.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesReata Pharmaceuticals (RETA)Buy $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesBiohaven Pharmaceutical (BHVN)Buy $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetCorbus Pharmaceuticals (CRBP)Buy $36.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetApellis Pharmaceuticals (APLS)Buy $53.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetAbeona Therapeutics (ABEO)Buy $36.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetMesoblast (MESO)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesZoetis (ZTS)Buy $98.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetAcelRx Pharmaceuticals (ACRX)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesDynavax Technologies (DVAX)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetAurinia Pharmaceuticals (AUPH)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetMomenta Pharmaceuticals (MNTA)Hold $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldSet Price TargetSpark Therapeutics (ONCE)Buy $103.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesIntercept Pharmaceuticals (ICPT)Overweight -> Overweight $170.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldReiteratesBiogen (BIIB)Overweight -> Overweight $400.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesCelgene (CELG)Overweight -> Overweight $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesTESARO (TSRO)Overweight -> Overweight $57.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesAmgen (AMGN)Neutral -> Neutral $223.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesPTC Therapeutics (PTCT)Overweight -> Overweight $66.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesGilead Sciences (GILD)Overweight -> Overweight $87.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesVertex Pharmaceuticals (VRTX)Overweight -> Overweight $217.00MediumView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesSarepta Therapeutics (SRPT)Overweight -> Overweight $217.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesIncyte (INCY)Neutral -> Neutral $73.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesMyokardia (MYOK)Overweight -> Overweight $90.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesAlnylam Pharmaceuticals (ALNY)Overweight -> Overweight $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesRegeneron Pharmaceuticals (REGN)Neutral -> Neutral $415.00HighView Rating Details  Share on Twitter  Share on StockTwits
10/1/2018Cantor FitzgeraldInitiatesPuma Biotechnology (PBYI)Overweight -> Overweight $75.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018Cantor FitzgeraldInitiatesBioMarin Pharmaceutical (BMRN)Overweight -> Overweight $126.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018Cantor FitzgeraldRaises TargetTeladoc Health (TDOC)Neutral -> Neutral$52.00 -> $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018Cantor FitzgeraldReiteratesMedEquities Realty Trust (MRT)Overweight -> Neutral$12.00 -> $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldSet Price TargetSpero Therapeutics (SPRO)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldSet Price TargetTherapeuticsMD (TXMD)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldSet Price TargetEli Lilly And Co (LLY)Buy $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/28/2018Cantor FitzgeraldSet Price TargetOpiant Pharmaceuticals (OPNT)Overweight -> Buy$32.00 -> $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldUpgradesHCP (HCP)Neutral -> Overweight$28.00 -> $29.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldSet Price TargetEvolus (EOLS)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldSet Price TargetGW Pharmaceuticals PLC- (GWPH)Buy $211.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldReiteratesTeva Pharmaceutical Industries (TEVA)Hold $25.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldSet Price TargetNovavax (NVAX)Hold $2.00N/AView Rating Details  Share on Twitter  Share on StockTwits
9/27/2018Cantor FitzgeraldSet Price TargetHeron Therapeutics (HRTX)Buy $50.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldInitiatesCIGNA (CI)Overweight $245.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldSet Price TargetAMAG Pharmaceuticals (AMAG)Hold $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldSet Price TargetT2 Biosystems (TTOO)Buy $11.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldSet Price TargetPfizer (PFE)Buy $45.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldSet Price TargetAldeyra Therapeutics (ALDX)Positive -> Overweight$23.00 -> $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldRaises TargetFactSet Research Systems (FDS)Neutral -> Neutral$203.00 -> $219.00LowView Rating Details  Share on Twitter  Share on StockTwits
9/26/2018Cantor FitzgeraldInitiatesEvofem Biosciences (EVFM)Overweight $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018Cantor FitzgeraldSet Price TargetAurinia Pharmaceuticals (AUPH)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018Cantor FitzgeraldSet Price TargetMarinus Pharmaceuticals (MRNS)Buy $19.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/25/2018Cantor FitzgeraldReiteratesInvesco DWA Utilities Momentum ETF (PTE)Buy $65.00MediumView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Cantor FitzgeraldSet Price TargetArena Pharmaceuticals (ARNA)Buy $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/24/2018Cantor FitzgeraldReiteratesAmarin (AMRN)Overweight -> Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
9/22/2018Cantor FitzgeraldSet Price TargetAnaptysBio (ANAB)Buy $124.00HighView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Tuesday at 03:01 PM ET.

MarketBeat Community Rating for Cantor Fitzgerald

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  7,087 (Vote Outperform)
Underperform Votes:  16,861 (Vote Underperform)
Total Votes:  23,948
MarketBeat's community ratings are surveys of what our community members think about Cantor Fitzgerald and other research firms. Vote "Outperform" if you believe Cantor Fitzgerald's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Cantor Fitzgerald's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel